首页> 外文OA文献 >Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network

【2h】

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network

机译：欧洲医药局批准的欧洲医药代谢疾病批准的28欧孤儿药物患者的可用性，可访问性和交付

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jean-Michel Heard; Charlotte Vrinten; Michael Schlander; Cinzia Maria Bellettato; Corine van Lingen; Maurizio Scarpa;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The European Reference Network Program for Hereditary Metabolic Diseases (MetabERN) [J] . Scarpa Maurizio Molecular genetics and metabolism . 2019,第2期

机译：欧洲遗传性代谢疾病的参考网络计划（Metabern）
2. PREDICTING ORPHAN DESIGNATION AND MARKETING AUTHORISATION BASED ON A REVIEW OF THE EUROPEAN MEDICINES AGENCY ORPHAN DISEASE REGISTER [J] . Sanchez Garcia J. J., Hill C. A., Hill D. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：基于对欧洲药品管理局ORPHAN疾病登记处的审查，预测ORPHAN的名称和营销授权
3. Re: Availability of Evidence of Benefits on Overall Survival and Quality of Life of Cancer Drugs Approved by European Medicines Agency: Retrospective Cohort Study of Drug Approvals 2009-2013 [J] . Madersbacher Stephan, Kramer Gero European urology . 2018,第4期

机译：Re：欧洲药物批准的癌症药物整体生存和生活质量的益处的效益的可用性：审查队列2009-2013的药物认证研究
4. Information about Medicines for Patients in Europe: To Impede or to Empower? [C] . Karel van der Waarde International conference on human-computer interaction;International conference on design, user experience and usability . 2014

机译：有关欧洲患者药物的信息：阻碍还是授权？
5. The Effects of Health System Reform on Access to Health Services and Medicines for Patients with Chronic Non-communicable Diseases in Hangzhou and Baoji, China. [D] . Jin, Nan. 2014

机译：杭州和宝鸡市卫生系统改革对慢性非传染性疾病患者获得医疗服务和药品的影响。
6. Availability accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network [O] . Jean-Michel Heard, Charlotte Vrinten, Michael Schlander, 2020

机译：MetabERN网络中欧洲药物管理局批准的28种遗传性代谢疾病孤儿药的可用性可及性和向患者的提供
7. PSY84 Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders [O] . Acquadro C., Perret C., Arnould B. 2014

机译：PSY84 Pro在欧洲药品管理局（Ema）批准的用于治疗淋巴增生性疾病的孤药中声称

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network

著录项

引文网络

相似文献

相关主题

期刊订阅